Literature DB >> 26652982

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.

Cloé Brami1, Ting Bao2, Gary Deng3.   

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting side-effect without any FDA-approved treatment option. Prior reviews focus mostly on pharmacological interventions, but nonpharmaceutical interventions have also been evaluated. A Web of Science and PubMed database search to identify relevant RCTs from January 2005 to May 2015 included the terms: CIPN, cancer; and supplements, vitamin E, goshajinkigan, kampo, acetyl-L-carnitine, carnitine, alpha-lipoic acid, omega-3, glutamine, or glutamate; or massage, acupuncture, mind-body practice, yoga, meditation, Tai-Chi, physical activity, or exercise. Of 1465 publications screened, 12 RCTs evaluated natural products and one evaluated electroacupuncture. Vitamin E may help prevent CIPN. L-Glutamine, goshajinkigan, and omega-3 are also promising. Acetyl-L-carnitine may worsen CIPN and alpha-lipoic acid activity is unknown. Electroacupuncture was not superior to placebo. No RCTs were published regarding other complementary therapies, although some studies mention positive incidental findings. Natural products and complementary therapies deserve further investigation, given the lack of effective CIPN interventions.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Complementary therapies; Dietary supplements; Integrative medicine; Natural products; Peripheral neuropathy; Platinum drugs; Randomized controlled trials

Mesh:

Substances:

Year:  2015        PMID: 26652982      PMCID: PMC4727999          DOI: 10.1016/j.critrevonc.2015.11.014

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  81 in total

1.  Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.

Authors:  Floortje Mols; Antoinetta J M Beijers; Gerard Vreugdenhil; Anna Verhulst; Goof Schep; Olga Husson
Journal:  J Cancer Surviv       Date:  2015-04-16       Impact factor: 4.442

Review 2.  Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review.

Authors:  Floortje Mols; Tonneke Beijers; Gerard Vreugdenhil; Lonneke van de Poll-Franse
Journal:  Support Care Cancer       Date:  2014-05-01       Impact factor: 3.603

Review 3.  Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.

Authors:  Guido Cavaletti; Paola Alberti; Paola Marmiroli
Journal:  Lancet Oncol       Date:  2011-06-28       Impact factor: 41.316

Review 4.  Neuropathic pain in cancer.

Authors:  M T Fallon
Journal:  Br J Anaesth       Date:  2013-07       Impact factor: 9.166

5.  Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.

Authors:  Antoinetta J M Beijers; Floortje Mols; Vivianne C G Tjan-Heijnen; Catharina G Faber; Lonneke V van de Poll-Franse; Gerard Vreugdenhil
Journal:  Acta Oncol       Date:  2014-11-24       Impact factor: 4.089

Review 6.  Chemotherapy-induced neuropathy.

Authors:  Anthony J Windebank; Wolfgang Grisold
Journal:  J Peripher Nerv Syst       Date:  2008-03       Impact factor: 3.494

7.  Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy.

Authors:  F Streckmann; S Kneis; J A Leifert; F T Baumann; M Kleber; G Ihorst; L Herich; V Grüssinger; A Gollhofer; H Bertz
Journal:  Ann Oncol       Date:  2014-02       Impact factor: 32.976

8.  Two styles of acupuncture for treating painful diabetic neuropathy--a pilot randomised control trial.

Authors:  Andrew C Ahn; Taher Bennani; Roy Freeman; Osama Hamdy; Ted J Kaptchuk
Journal:  Acupunct Med       Date:  2007-06       Impact factor: 2.267

9.  Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.

Authors:  Zohreh Ghoreishi; Ali Esfahani; Abolghasem Djazayeri; Mahmoud Djalali; Banafsheh Golestan; Hormoz Ayromlou; Shahriar Hashemzade; Mohammad Asghari Jafarabadi; Vahid Montazeri; Seyed Ali Keshavarz; Masoud Darabi
Journal:  BMC Cancer       Date:  2012-08-15       Impact factor: 4.430

10.  (R)-(+)-α-lipoic acid protected NG108-15 cells against H₂O₂-induced cell death through PI3K-Akt/GSK-3β pathway and suppression of NF-κβ-cytokines.

Authors:  Muhamad Noor Alfarizal Kamarudin; Nur Afiqah Mohd Raflee; Sharifah Salwa Syed Hussein; Jia Ye Lo; Hadi Supriady; Habsah Abdul Kadir
Journal:  Drug Des Devel Ther       Date:  2014-10-08       Impact factor: 4.162

View more
  29 in total

1.  Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.

Authors:  Nobuaki Hoshino; Riki Ganeko; Koya Hida; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2017-12-21       Impact factor: 3.402

2.  Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.

Authors:  Heather Greenlee; Katherine D Crew; Jillian Capodice; Danielle Awad; Donna Buono; Zaixing Shi; Anne Jeffres; Sharon Wyse; Wendy Whitman; Meghna S Trivedi; Kevin Kalinsky; Dawn L Hershman
Journal:  Breast Cancer Res Treat       Date:  2016-03-25       Impact factor: 4.872

3.  A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy.

Authors:  K Li; D Giustini; D Seely
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

4.  Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study.

Authors:  Sarah Prinsloo; Diane Novy; Larry Driver; Randall Lyle; Lois Ramondetta; Cathy Eng; Jennifer McQuade; Gabriel Lopez; Lorenzo Cohen
Journal:  Cancer       Date:  2017-03-03       Impact factor: 6.860

5.  Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study.

Authors:  Isacco Desideri; Giulio Francolini; Carlotta Becherini; Francesca Terziani; Camilla Delli Paoli; Emanuela Olmetto; Mauro Loi; Marco Perna; Icro Meattini; Vieri Scotti; Daniela Greto; Pierluigi Bonomo; Susanna Sulprizio; Lorenzo Livi
Journal:  Med Oncol       Date:  2017-02-15       Impact factor: 3.064

Review 6.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

7.  Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Authors:  Ian R Kleckner; Charles Kamen; Jennifer S Gewandter; Nimish A Mohile; Charles E Heckler; Eva Culakova; Chunkit Fung; Michelle C Janelsins; Matthew Asare; Po-Ju Lin; Pavan S Reddy; Jeffrey Giguere; Jeffrey Berenberg; Shelli R Kesler; Karen M Mustian
Journal:  Support Care Cancer       Date:  2017-12-14       Impact factor: 3.603

8.  Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial.

Authors:  Philipp Zimmer; Sina Trebing; Ursula Timmers-Trebing; Alexander Schenk; Rainer Paust; Wilhelm Bloch; Roland Rudolph; Fiona Streckmann; Freerk T Baumann
Journal:  Support Care Cancer       Date:  2017-09-30       Impact factor: 3.603

Review 9.  Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis.

Authors:  Jie Chen; Haili Shan; Wenjun Yang; Jiali Zhang; Haibin Dai; Ziqi Ye
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

10.  Symptom burden and willingness to participate: implications for herbal clinical trials in lung cancer.

Authors:  Jie Liu; Wei Hou; Mithat Gönen; Christina Seluzicki; Susan Qing Li; Jun J Mao
Journal:  Ann Palliat Med       Date:  2020-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.